Cancer Immunotherapy Is More Effective in Irradiated Tumors in Preclinical Mouse Model of Melanoma
Jingjing Wang(University of North Carolina at Chapel Hill), Andrew Z. Wang(Ocean NanoTech (United States)), Kyle Wagner(University of North Carolina at Chapel Hill), Junnian Zheng(Xuzhou Medical College), Liantao Li(Jiangsu University), Yuxia Zhao(Shandong University)
International Journal of Radiation Oncology*Biology*Physics
September 1, 2019
Cited by 1
Related Papers
Ki67 is a promising molecular target in the diagnosis of cancer (Review)
|Molecular Medicine Reports|2014|859
HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy
|Molecular Pharmaceutics|2011|219
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136